Literature DB >> 9747961

Residual beta-cell function and spontaneous clinical remission in type 1 diabetes mellitus: the role of puberty.

R Bonfanti1, E Bognetti, F Meschi, A Brunelli, M C Riva, M R Pastore, G Calori, G Chiumello.   

Abstract

To investigate the role of puberty on spontaneous clinical remission and on secretion of residual C-peptide during the first year of type 1 diabetes mellitus, we studied 77 pre-pubertal, 39 pubertal and 41 post-pubertal type 1 diabetic patients. Spontaneous partial clinical remission (HbA1c within the normal range and insulin dose less than 0.3 U x kg(-1) body weight x day(-1) lasting for at least 10 days) decreased with duration of diabetes: months 3 vs 6 vs 12, respectively 13 vs 7 vs 4% (P<0.025). Remission was higher in post-pubertal than pubertal and prepubertal patients: month 6 respectively 20 vs 5 vs 1% (P<0.001). Secretion of C-peptide was significantly lower in pre-pubertal than the other two groups of patients. Basal and stimulated C-peptide secretion were higher in patients in clinical remission than in those who were not: basal value 0.4 (0.26-0.53) vs 0.28 (0.14-0.4) nmol/l (P<0.05); stimulated value 0.63 (0.5-0.95) vs 0.56 (0.31-0.74) nmol/l (P<0.05). Spontaneous remission is less frequent in children and adolescent patients than in adult post-pubertal patients, but different mechanisms may be involved. Low residual insulin secretion seems implicated in children meanwhile low insulin sensitivity could be more important in pubertal patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9747961     DOI: 10.1007/s005920050110

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  11 in total

Review 1.  Type 1 diabetes: A predictable disease.

Authors:  Kimber M Simmons; Aaron W Michels
Journal:  World J Diabetes       Date:  2015-04-15

2.  Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis.

Authors:  A Kaas; C Pfleger; L Hansen; K Buschard; N C Schloot; B O Roep; H B Mortensen
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

3.  Dynamic changes in CD4+ CD25+(high) T cell apoptosis after the diagnosis of type 1 diabetes.

Authors:  S Glisic-Milosavljevic; T Wang; M Koppen; J Kramer; S Ehlenbach; J Waukau; P Jailwala; S Jana; R Alemzadeh; S Ghosh
Journal:  Clin Exp Immunol       Date:  2007-08-17       Impact factor: 4.330

4.  Residual β-Cell function 3-6 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents.

Authors:  Jesper S Sørensen; Jesper Johannesen; Flemming Pociot; Kurt Kristensen; Jane Thomsen; N Thomas Hertel; Per Kjaersgaard; Caroline Brorsson; Niels H Birkebaek
Journal:  Diabetes Care       Date:  2013-08-29       Impact factor: 19.112

5.  Transcriptional signatures as a disease-specific and predictive inflammatory biomarker for type 1 diabetes.

Authors:  H Levy; X Wang; M Kaldunski; S Jia; J Kramer; S J Pavletich; M Reske; T Gessel; M Yassai; M W Quasney; M K Dahmer; J Gorski; M J Hessner
Journal:  Genes Immun       Date:  2012-09-13       Impact factor: 2.676

6.  Spontaneous complete remission of type 1 diabetes mellitus in an adult - review and case report.

Authors:  Harsha Moole; Vishnu Moole; Adrija Mamidipalli; Sowmya Dharmapuri; Raghuveer Boddireddy; Deepak Taneja; Hady Sfeir; Sonia Gajula
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-10-19

7.  Factors Influencing Frequency and Duration of Remission in Children and Adolescents Newly Diagnosed with Type 1 Diabetes.

Authors:  Özlem Kara; İhsan Esen; Derya Tepe
Journal:  Med Sci Monit       Date:  2018-08-28

8.  New definition for the partial remission period in children and adolescents with type 1 diabetes.

Authors:  Henrik B Mortensen; Philip Hougaard; Peter Swift; Lars Hansen; Reinhard W Holl; Hilary Hoey; Hilde Bjoerndalen; Carine de Beaufort; Francesco Chiarelli; Thomas Danne; Eugen J Schoenle; Jan Aman
Journal:  Diabetes Care       Date:  2009-05-12       Impact factor: 17.152

9.  Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation.

Authors:  Parthav Jailwala; Jill Waukau; Sanja Glisic; Srikanta Jana; Sarah Ehlenbach; Martin Hessner; Ramin Alemzadeh; Shigemi Matsuyama; Purushottam Laud; Xujing Wang; Soumitra Ghosh
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

10.  Residual β-Cell Function in Type 1 Diabetes Followed for 2 Years after 3C Study.

Authors:  Kun Lin; Xiaoping Yang; Yixi Wu; Shuru Chen; Qiong Zeng
Journal:  J Diabetes Res       Date:  2021-06-28       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.